Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by VectorBuilder

News headline image
VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder to Invest $50 Million in Chicago Biomanufacturing and R&D Center
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Secures European Patent for MiniVec™, a Plasmid Backbone Advancing Safety and Manufacturability in Genetic Medicine
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder to Present on Advancing AAV-Based Therapies at ARVO 2026
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Introduces High-Stability MuteFree™ AAV to Improve Gene Therapy Manufacturing Reliability
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Redefines Plasmid Standards with miniVec
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Wins Two IMAPAC Awards, Cementing Leadership in Gene Therapy and CDMO Innovation
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder Wins BioIndustrial Innovation of the Year Award
From VectorBuilder
Via Business Wire
News headline image
VectorBuilder’s Chief Scientist, Dr. Bruce Lahn Named to the 2024 PharmaVoice 100
From VectorBuilder
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.